Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.

S Kumakura, H Shibata, K Onoda, N Nishimura, C Matsuda, M Hirose
Author Information
  1. S Kumakura: Department of Medical Education and Research, Faculty of Medicine, Shimane University, Japan.

Abstract

A seroprevalence survey on measles, mumps, rubella and varicella was conducted on healthcare workers (HCWs) at Shimane University Hospital, Japan utilizing an enzyme immunoassay. Of 1811 HCWs tested, 91.8% were seropositive to measles, 92.1% to mumps, 89.5% to rubella and 96.3% to varicella. Sex-related differences in seroprevalence were found in rubella (males vs. females: 84.7 vs. 92.2%, P < 0.001). Moreover, males aged 30-39 years were most susceptible to rubella (22.4%), which may be attributed to the design of childhood immunization programmes in Japan. Individuals aged ≤ 29 years were more susceptible to measles (14.3%) and mumps (10.9%), compared to other age groups. There were no significant sex- and age-related differences in varicella seroprevalence. The physician occupational group was more susceptible to rubella, but no significant occupational-related difference was observed in the other diseases. Susceptible subjects, with negative or equivocal serological results were given a vaccine which induced seroconversion in most vaccinees. Seroconversion occurred more frequently in the equivocal group than in the negative group. These findings provide a new insight for the seroprevalence survey of vaccine-preventable diseases in Japanese HCWs with special reference to vaccine efficacy.

References

  1. Infect Control Hosp Epidemiol. 1998 Jun;19(6):407-63 [PMID: 9669622]
  2. Vaccine. 2012 Sep 21;30(43):6180-5 [PMID: 22871352]
  3. J Infect Dis. 2008 Mar 1;197 Suppl 2:S185-90 [PMID: 18419395]
  4. J Health Popul Nutr. 2009 Feb;27(1):80-6 [PMID: 19248651]
  5. J Infect Dis. 2008 Apr 1;197(7):950-6 [PMID: 18419470]
  6. Clin Vaccine Immunol. 2006 Jul;13(7):764-7 [PMID: 16829613]
  7. N Engl J Med. 2007 Nov 8;357(19):1903-15 [PMID: 17989383]
  8. Epidemiol Infect. 2001 Apr;126(2):249-59 [PMID: 11349976]
  9. Am J Clin Pathol. 1996 Aug;106(2):170-4 [PMID: 8712168]
  10. J Infect Chemother. 2008 Aug;14(4):291-5 [PMID: 18709532]
  11. J Hosp Infect. 2002 Jun;51(2):133-5 [PMID: 12090801]
  12. Am J Infect Control. 2006 Nov;34(9):583-7 [PMID: 17097453]
  13. J Infect Dis. 1997 Apr;175(4):749-55 [PMID: 9086126]
  14. Am J Infect Control. 2003 May;31(3):157-62 [PMID: 12734521]
  15. Infect Control Hosp Epidemiol. 2004 Jul;25(7):591-4 [PMID: 15301032]
  16. MMWR Morb Mortal Wkly Rep. 2008 Sep 26;57(38):1049-52 [PMID: 18818586]
  17. Infect Control Hosp Epidemiol. 2006 Nov;27(11):1178-83 [PMID: 17080374]
  18. MMWR Recomm Rep. 1997 Dec 26;46(RR-18):1-42 [PMID: 9427216]
  19. J Clin Virol. 2009 Jan;44(1):9-14 [PMID: 18823815]
  20. Aust N Z J Public Health. 2008 Aug;32(4):367-71 [PMID: 18782402]
  21. J Med Virol. 2000 Dec;62(4):511-7 [PMID: 11074481]

MeSH Term

Adult
Antibodies, Viral
Cohort Studies
Female
Health Personnel
Humans
Japan
Male
Measles-Mumps-Rubella Vaccine
Middle Aged
Seroepidemiologic Studies
Vaccination

Chemicals

Antibodies, Viral
Measles-Mumps-Rubella Vaccine

Word Cloud

Created with Highcharts 10.0.0rubellaseroprevalencemeaslesmumpsvaricellasurveyHCWsdifferencessusceptiblegroupvaccinehealthcareworkersJapan923%malesvsagedyearsagesignificantoccupational-relateddiseasesnegativeequivocalefficacyconductedShimaneUniversityHospitalutilizingenzymeimmunoassay1811tested918%seropositive1%895%96Sex-relatedfoundfemales:8472%P<0001Moreover30-39224%mayattributeddesignchildhoodimmunizationprogrammesIndividuals2914109%comparedgroupssex-age-relatedphysicianoccupationaldifferenceobservedSusceptiblesubjectsserologicalresultsgiveninducedseroconversionvaccineesSeroconversionoccurredfrequentlyfindingsprovidenewinsightvaccine-preventableJapanesespecialreferenceSeroprevalenceantibodiesJapan:sex

Similar Articles

Cited By (23)